Applied Therapeutics Statistics Share Statistics Applied Therapeutics has 141.58M
shares outstanding. The number of shares has increased by 23.27%
in one year.
Shares Outstanding 141.58M Shares Change (YoY) 23.27% Shares Change (QoQ) 21.67% Owned by Institutions (%) 99.99% Shares Floating 116.52M Failed to Deliver (FTD) Shares 111,848 FTD / Avg. Volume 4.94%
Short Selling Information The latest short interest is 18.08M, so 12.77% of the outstanding
shares have been sold short.
Short Interest 18.08M Short % of Shares Out 12.77% Short % of Float 12.86% Short Ratio (days to cover) 5.72
Valuation Ratios The PE ratio is -1.13 and the forward
PE ratio is -0.96.
Applied Therapeutics's PEG ratio is
0.02.
PE Ratio -1.13 Forward PE -0.96 PS Ratio 262.57 Forward PS 0.4 PB Ratio 2.1 P/FCF Ratio -1.42 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Applied Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.06,
with a Debt / Equity ratio of 0.05.
Current Ratio 3.06 Quick Ratio 3.06 Debt / Equity 0.05 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $13K Profits Per Employee $-3.02M Employee Count 35 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -90.19% in the
last 52 weeks. The beta is 1.82, so Applied Therapeutics's
price volatility has been higher than the market average.
Beta 1.82 52-Week Price Change -90.19% 50-Day Moving Average 0.4 200-Day Moving Average 2.21 Relative Strength Index (RSI) 67.03 Average Volume (20 Days) 2,263,137
Income Statement In the last 12 months, Applied Therapeutics had revenue of 455K
and earned -105.62M
in profits. Earnings per share was -0.76.
Revenue 455K Gross Profit 30K Operating Income -104.3M Net Income -105.62M EBITDA -103.87M EBIT -104.3M Earnings Per Share (EPS) -0.76
Full Income Statement Balance Sheet The company has 79.4M in cash and 2.79M in
debt, giving a net cash position of 76.6M.
Cash & Cash Equivalents 79.4M Total Debt 2.79M Net Cash 76.6M Retained Earnings -574.21M Total Assets 56.91M Working Capital 36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -84.31M
and capital expenditures 0, giving a free cash flow of -84.31M.
Operating Cash Flow -84.31M Capital Expenditures n/a Free Cash Flow -84.31M FCF Per Share -0.6
Full Cash Flow Statement Margins Gross margin is 6.59%, with operating and profit margins of -22922.86% and -23214.07%.
Gross Margin 6.59% Operating Margin -22922.86% Pretax Margin -23214.07% Profit Margin -23214.07% EBITDA Margin -22829.23% EBIT Margin -22922.86% FCF Margin -18528.57%
